Supreme Court: DNA database retention regs are unlawful
By Lewis Page,
The Register
| 05. 18. 2011
[United Kingdom]
The Supreme Court has ruled that guidance on the running of the national DNA database – which states that all collected DNA signatures should be retained other than in "exceptional" circumstances – is unlawful. However the court, noting that Parliament is considering the matter, has declined to specify any remedy for the situation.
The ruling (
53-page PDF/182KB [1]) follows appeals brought by two men, referred to as GC and C, against judgments which had seen their signatures kept on file indefinitely, even though GC had been released without charge following his sampling and C – facing allegations of rape – had been acquitted.
Police routinely collect DNA data on people they arrest, and in the vast majority of cases this data is kept on file indefinitely even if no charges or convictions ensue. The European Court of Human Rights ruled against this practice in 2008, but current guidance from the Association of Chief Police Officers (ACPO) states that chief constables have discretion to keep DNA data on file – even in the case of innocent persons requesting to have...
Related Articles
By Ron Leuty, San Francisco Business Times | 06.16.2025
23andMe's two-step sale to a nonprofit led by former CEO Anne Wojcicki is nothing more than a dance around California's genetic privacy law, state Attorney General Rob Bonta said in a filing late Monday, one day before a judge will...
By Angus Liu, Fierce Pharma | 06.16.2025
A second patient has died following treatment with Sarepta Therapeutics’ Elevidys, raising more doubts about the Duchenne muscular dystrophy (DMD) gene therapy’s safety profile.
Sarepta and its ex-U.S. partner Roche reported the death early Sunday. Like the first case, disclosed...
By Sophie Alexander and Ike Swetlitz, Bloomberg | 06.25.2025
A California-startup focused on genetically editing human embryos — a step toward creating so-called designer babies — is raising money as many of Silicon Valley’s ultra-rich turn their attention to one of the most controversial technologies in medicine.
Bootstrap Bio...
By Siddhi Mahatole and Mariam E. Sunny, Reuters | 06.13.2025
Anne Wojcicki is set to regain control of 23andMe after a $305 million bid from a nonprofit she controls topped Regeneron Pharmaceuticals' (REGN.O), opens new tab offer for the DNA-testing company in a bankruptcy auction.
Last month, Regeneron agreed to...